Responses
Clinical/translational cancer immunotherapy
Original research
Human CD141+ dendritic cells (cDC1) are impaired in patients with advanced melanoma but can be targeted to enhance anti-PD-1 in a humanized mouse model
Compose a Response to This Article
Other responses
No responses have been published for this article.
